Elevate your metabolic health with SugarMD Super Berberine, an innovative supplement that combines dihydroberberine (DHB) and 100% pure Ceylon cinnamon to deliver superior support for glucose metabolism¹, weight management, and cellular health. With five times greater bioavailability than traditional berberine, dihydroberberine ensures effective and long-lasting benefits. Paired with the safe and natural properties of Ceylon cinnamon, this advanced formula provides a comprehensive approach to promoting metabolic wellness naturally.
Unlike cassia cinnamon, which contains coumarin, Ceylon cinnamon is a safer, more effective alternative for daily use. Together, these powerhouse ingredients work synergistically to support balanced blood sugar², reduce inflammation, and enhance metabolic function³.
Disclaimer:
This supplement is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Consult your healthcare provider before use, especially if pregnant, nursing, taking medications, or managing a medical condition. Not for individuals under 18. Gallery images are for reference only, not to scale, and may not show all ingredients. Actual product details may vary.
Quality Commitment:
At SugarMD, “Lab Tested for Purity” means every ingredient undergoes rigorous testing to ensure it’s free from contaminants like pesticides and heavy metals. We prioritize only the cleanest, most natural ingredients, crafted to meet high wellness standards so you can trust SugarMD for yourself and those you care about.
- Moon, Jessica M., Kayla M. Ratliff, Anthony M. Hagele, Richard A. Stecker, Petey W. Mumford, and Chad M. Kerksick. 2022. "Absorption Kinetics of Berberine and Dihydroberberine and Their Impact on Glycemia: A Randomized, Controlled, Crossover Pilot Trial" Nutrients 14, no. 1: 124.
- Ranasinghe, P., Galappaththy, P., G.R. Constantine, et al. "Cinnamomum zeylanicum (Ceylon Cinnamon) as a Potential Pharmaceutical Agent for Type-2 Diabetes Mellitus: Study Protocol for a Randomized Controlled Trial." Trials 18 (2017): 446.
- Ranasinghe, P., Galappaththy, P., G.R. Constantine, et al. "Cinnamomum zeylanicum (Ceylon Cinnamon) as a Potential Pharmaceutical Agent for Type-2 Diabetes Mellitus: Study Protocol for a Randomized Controlled Trial." Trials 18 (2017): 446.
